ResearcherQueen's University BelfastNo recent work listed
Michael C. Johnston
Matched on OpenAlex author ID A5109260496. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2020: 1 paper · 2021: 1 paper
Papers 2
- Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance. First author DOI 10.3390/cancers13246175↗
- DR5-targeted, chemotherapeutic drug-loaded nanoparticles induce apoptosis and tumor regression in pancreatic cancer in vivo models. Co-author DOI 10.1016/j.jconrel.2020.05.046↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Michelle K. Greene · 2 shared papers, 2020–2021 · strength 0.31
- Paper Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance. DOI 10.3390/cancers13246175↗
- Paper DR5-targeted, chemotherapeutic drug-loaded nanoparticles induce apoptosis and tumor regression in pancreatic cancer in … DOI 10.1016/j.jconrel.2020.05.046↗
- Christopher J. Scott · 2 shared papers, 2020–2021 · strength 0.31
- Paper Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance. DOI 10.3390/cancers13246175↗
- Paper DR5-targeted, chemotherapeutic drug-loaded nanoparticles induce apoptosis and tumor regression in pancreatic cancer in … DOI 10.1016/j.jconrel.2020.05.046↗
- Sandra Roche · 1 shared paper, 2020 · strength 0.09
- Robert M. Straubinger · 1 shared paper, 2020 · strength 0.09
- Martin M. Clynes · 1 shared paper, 2020 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.